AcuityMD Launches Enhanced Referral Pathways to Boost Patient Access to MedTech Innovations

AcuityMD, a leading MedTech intelligence platform, recently announced the expansion of its Care Journeys solution with enhanced physician referral networks to increase patient access to medical technology innovations. The new feature, called Referral Pathways, aims to help MedTech companies and healthcare providers (HCPs) deliver new treatment options to more patients by providing a comprehensive view of patient referral pathways. Launched in October 2024, AcuityMD Care Journeys was initially designed to assist MedTech companies in demonstrating the improved clinical and financial outcomes of their technologies for patients with complex diagnoses and treatment journeys. This helped drive product adoption with hospitals and physicians. The addition of Referral Pathways further enhances this capability by integrating sophisticated, data-driven visualizations that empower MedTech companies to connect upstream referrers to HCPs offering differentiated treatments. This more complete view of the care journey enables commercial teams to better target their innovations, ensuring that they reach the right physicians and ultimately benefit more patients. Physicians often face overwhelming workloads, with 80% reporting being overworked in a 2024 survey. The aging population and increased prevalence of patients with multiple comorbidities, such as obesity, diabetes, asthma, sleep apnea, and kidney disease, exacerbate this issue. Coupled with a severe physician shortage, these factors make it challenging for providers to stay updated on the latest medical innovations. Additionally, the rapid growth of the MedTech industry, driven by advances in AI, robotics, and digital health, is expected to reach $800 billion by 2030, further complicating the landscape. To address these challenges, MedTech companies have traditionally relied on regional and local educational events to engage HCPs, but these efforts often fall short due to incomplete referral data that typically captures only the most recent patient encounters. As a result, many patients miss out on potentially more effective treatments simply because their providers are unaware of the latest options. AcuityMD’s Referral Pathways overcomes these barriers by mapping the entire referral network of a provider, including upstream HCPs who diagnose specific conditions in the same geographic area where HCPs offer a company’s therapy. This unique approach helps MedTech teams identify key healthcare providers diagnosing conditions like benign prostatic hyperplasia (BPH) and raise their awareness of innovative treatments such as the UroLift System offered by Teleflex Incorporated. Teleflex, a global leader in medical technologies, has been an early adopter of Referral Pathways, using it to increase the adoption of the UroLift System, a minimally invasive treatment for BPH that significantly improves quality of life for millions of men in the U.S. Anthony Parrillo, Global Vice President of Marketing at Teleflex, praised the impact of Referral Pathways, stating, “Over 14 million men in the U.S. are living with BPH symptoms, and only a small percentage (3%) opt for surgical treatment. Referral Pathways allows us to pinpoint HCPs who frequently diagnose BPH in specific markets, increasing their awareness of the UroLift System procedure and providing them with a physician locator tool. This data from AcuityMD has been instrumental in optimizing our sales efforts and expanding the reach of our minimally invasive treatment.” Megan Wilson, Director of Product Management at AcuityMD, emphasized the broader significance of the new feature: “Referral Pathways elevates MedTech commercialization by not only highlighting the clinical opportunities around an HCP but also revealing new strategic referral pathways. By identifying the most relevant and impactful connections, sales teams can forge more meaningful relationships, ensuring that patients receive the best possible care through the latest innovations.” Referral Pathways is now generally available on the AcuityMD platform, and the company will showcase the feature at upcoming industry conferences. AcuityMD is a trusted MedTech intelligence platform used by over 300 MedTech companies, including six of the top 10. The platform supports commercial leaders in identifying target markets, surfacing top opportunities, and growing their businesses. Serving a wide range of customers from pre-commercial startups to large enterprises, AcuityMD is committed to delivering insightful data that accelerates the adoption of medical technology, ultimately improving patient outcomes. Industry insiders view AcuityMD's expansion as a significant step forward in addressing the disconnect between rapidly advancing medical technologies and the overburdened healthcare system. By providing HCPs with a clearer understanding of their referral networks and the latest treatment options, AcuityMD is helping to bridge the gap and ensure that patients receive the best possible care.